Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A injection for benign prostatic hyperplasia
IRCT201008174582N1Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of botulinum toxin type A in benign prostatic hyperplasia (BPH), sponsored by Guilan University of Medical Sciences. Started Jun 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT201008174582N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201008174582N1.